dexrapid vet. 2 mg/ml injektioneste, liuos
richter pharma ag - dexamethasone sodium phosphate - injektioneste, liuos - 2 mg/ml - deksametasoni
pylclari
curium pet france - piflufolastat (18f) - prostatiset kasvaimet - diagnostiset radiofarmaseuttiset valmisteet - tämä lääkevalmiste on tarkoitettu vain diagnostiseen käyttöön. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
prednicortone vet 5 mg tabletti
dechra regulatory b.v. - prednisolone - tabletti - 5 mg - prednisoloni
prednicortone vet 20 mg tabletti
dechra regulatory b.v. - prednisolone - tabletti - 20 mg - prednisoloni
dexacortone vet 2 mg purutabletti
le vet. beheer b.v. - dexamethasone - purutabletti - 2 mg - deksametasoni
dexacortone vet 0.5 mg purutabletti
le vet. beheer b.v. - dexamethasone - purutabletti - 0.5 mg - deksametasoni
dexaject 2 mg/ml injektioneste, liuos
dopharma research b.v. - dexamethasone sodium phosphate - injektioneste, liuos - 2 mg/ml - deksametasoni
trovex vet 1 mg/ml injektioneste, suspensio
emdoka - dexamethasone isonicotinate - injektioneste, suspensio - 1 mg/ml - deksametasoni
resflor vet. injektioneste, liuos
intervet international b.v. - flunixin meglumine, florfenicol - injektioneste, liuos
hexabrix 320 mg i/ml injektioneste, liuos
guerbet - meglumini ioxaglas,natrii ioxaglas - injektioneste, liuos - 320 mg i/ml - joksagliinihappo